During the past decade, Khechinashvili University Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 8 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Khechinashvili University Hospital" #1 sponsor was "Celgene" with 4 trials, followed by "H. Lundbeck A/S" with 2 trials sponsored, "Optinose US Inc." with 2 trials sponsored, "Actelion" with 1 trials sponsored and "BioAegis Therapeutics Inc." with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Khechinashvili University Hospital" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "PSI CRO" with 1 trials as a collaborator and "Pharma Consulting Group AB" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Khechinashvili University Hospital" are "Multiple Sclerosis" (4 trials), "Breast Cancer" (2 trials), "Chronic Rhinosinusitis" (2 trials), "Relapsing Multiple Sclerosis" (2 trials) and "Advanced Metastatic (Stage IV) Colorectal Cancer" (1 trials). Many other conditions were trialed in "Khechinashvili University Hospital" in a lesser frequency.

Most popular intervention types in "Khechinashvili University Hospital" are "Drug" (22 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ozanimod" (3 trials), "Eptinezumab" (2 trials), "Herceptin" (2 trials) and "Interferon beta-1a" (2 trials). Other intervention names were less common.

The vast majority of trials in "Khechinashvili University Hospital" are 18 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Khechinashvili University Hospital". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Khechinashvili University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Khechinashvili University Hospital, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".